ArticleEmerging microbes & infections2017
Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea.
Article in Emerging microbes & infections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.
- Use of personal protective equipment to protect against respiratory infections in Pakistan: A systematic review.Journal of infection and public health · 2020Pooled it
- Use of personal protective equipment to protect against respiratory infections in Pakistan: A systematic review.Journal of infection and public healthPooled it
- Thinking globally for pandemic early warning systems.Nature medicine · 2025Article
- Stochastic modeling of intra- and inter-hospital transmission in Middle East respiratory syndrome outbreak.PloS one · 2025Article
- Design and psychometrics of risk assessment tool for makeshift hospitals: Focusing on pandemics.Heliyon · 2023Article
- Apalutamide Prevents SARS-CoV-2 Infection in Lung Epithelial Cells and in Human Nasal Epithelial Cells.International journal of molecular sciences · 2023Article
- Overlooked sex and gender aspects of emerging infectious disease outbreaks: Lessons learned from COVID-19 to move towards health equity in pandemic response.Frontiers in global women's health · 2023Review
- Cross-sectional study of Middle East respiratory syndrome coronavirus in humans and dromedary camels in Diyala, Iraq.Turkish journal of medical sciences · 2022Article
- COVID-19 outbreak in a psychiatric hospital: what makes it worse?Annals of general psychiatry · 2022Article
- Sex differences in COVID-19 mortality in the Netherlands.Infection · 2022Article
- SARS-COV-2 - the pandemic of the XXI century, clinical manifestations - neurological implications.Journal of medicine and life · 2022Review
- Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human.Vaccines · 2022Review
- Global research activity on mathematical modeling of transmission and control of 23 selected infectious disease outbreak.Globalization and health · 2022Article
- Sex-disaggregated data matters: tracking the impact of COVID-19 on the health of women and men.Economia politica (Bologna, Italy) · 2022Article
- Sex-based differences in severity and mortality in COVID-19.Reviews in medical virology · 2021Review
- Personal and vaccination history as factors associated with SARS-CoV-2 infection.Medicina clinica (English ed.) · 2021Article
- [Personal and vaccination history as factors associated with SARS-CoV-2 infection].Medicina clinica · 2021Article
- Important scoring systems for assessing the severity of COVID-19 based on COVID-19-related deaths in Wuhan, China.Emergency and critical care medicine · 2021Article
- Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Pathology, research and practice · 2021Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MERS-CoV infection emerged in the Kingdom of Saudi Arabia (KSA) in 2012 and has spread to 26 countries. However, 80% of all cases have occurred in KSA. The largest outbreak outside KSA occurred in South Korea (SK) in 2015. In this report, we describe an epidemiological comparison of the two outbreaks. Data from 1299 cases in KSA (2012-2015) and 186 cases in SK (2015) were collected from publicly available resources, including FluTrackers, the World Health Organization (WHO) outbreak news and the Saudi MOH (MOH). Descriptive analysis, t-tests, Chi-square tests and binary logistic regression were conducted to compare demographic and other characteristics (comorbidity, contact history) of cases by nationality. Epidemic curves of the outbreaks were generated. The mean age of cases was 51 years in KSA and 54 years in SK. Older males (⩾70 years) were more likely to be infected or to die from MERS-CoV infection, and males exhibited increased rates of comorbidity in both countries. The epidemic pattern in KSA was more complex, with animal-to-human, human-to-human, nosocomial and unknown exposure, whereas the outbreak in SK was more clearly nosocomial. Of the 1186 MERS cases in KSA with reported risk factors, 158 (13.3%) cases were hospital associated compared with 175 (94.1%) in SK, and an increased proportion of cases with unknown exposure risk was found in KSA (710, 59.9%). In a globally connected world, travel is a risk factor for emerging infections, and health systems in all countries should implement better triage systems for potential imported cases of MERS-CoV to prevent large epidemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.